Breakthrough in 3D-Printed Immediate-Release Tablets
Advancements in Pharmaceutical Manufacturing
Scientists from Germany and Switzerland have achieved a significant milestone by utilizing 3D-printing technology to create immediate-release tablets. This innovation marks a pivotal moment in the pharmaceutical industry, as 3D printing holds immense potential for transforming drug manufacturing processes. Unlike traditional methods, the additive manufacturing approach allows for the layer-by-layer printing of medications, eliminating the need for complex compression or molding techniques.
Benefits of 3D Printing in Pharmaceuticals
The advantages of 3D printing over conventional pharmaceutical manufacturing are substantial. This technology facilitates personalized medication production in smaller quantities, streamlines the operational process, enhances drug loading capabilities, and minimizes material waste.
Challenges in 3D-Printed Tablet Development
Despite its promise, the application of 3D printing in creating tablets using fused deposition modeling faces several challenges. One notable issue is that these tablets often exhibit poor solubility and low dissolution rates due to the polymers used and the density of the solidified melt, which can hinder bioavailability when administered orally.
New Insights on Porosity and Solubility
A recent study published in the Journal of Pharmaceutical Research sheds light on the relationship between porosity and solubility in 3D-printed tablets. Researchers found that by halving the infill rate of pharmaceutical-grade polymers, they could significantly accelerate drug release times, achieving complete release in just three minutes. This rapid release is attributed to the increased surface area available for dissolution, a feat that traditional powder compression methods cannot replicate.
Temperature Control in 3D Printing
Additionally, the scientists discovered that by gradually raising the extrusion temperature, they could effectively manage the printing temperature down to 100°C. This breakthrough offers valuable insights into the fused deposition modeling process for immediate-release tablets and sets the stage for the future development of thermally unstable drugs.
Conclusion
This research represents a significant advancement in the field of 3D printing for pharmaceuticals, paving the way for innovative applications in drug delivery systems.
Reference
Kempin, W., Domsta, V., Grathoff, G. et al. Immediate Release 3D-Printed Tablets Produced Via Fused Deposition Modeling of a Thermo-Sensitive Drug. Pharmaceutical Research (2018) 35:124. DOI 10.1007/s11095-018-2405-6.